209 related articles for article (PubMed ID: 17497357)
1. Fast-dissolving tablets of glyburide based on ternary solid dispersions with PEG 6000 and surfactants.
Cirri M; Maestrelli F; Corti G; Mura P; Valleri M
Drug Deliv; 2007 Apr; 14(4):247-55. PubMed ID: 17497357
[TBL] [Abstract][Full Text] [Related]
2. Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique.
Valleri M; Mura P; Maestrelli F; Cirri M; Ballerini R
Drug Dev Ind Pharm; 2004 May; 30(5):525-34. PubMed ID: 15244088
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of fast-dissolving tablet formulations of glyburide based on solid self-microemulsifying systems.
Cirri M; Roghi A; Valleri M; Mura P
Eur J Pharm Biopharm; 2016 Jul; 104():19-29. PubMed ID: 27091783
[TBL] [Abstract][Full Text] [Related]
4. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781.
Goddeeris C; Willems T; Van den Mooter G
Eur J Pharm Sci; 2008 Aug; 34(4-5):293-302. PubMed ID: 18602800
[TBL] [Abstract][Full Text] [Related]
5. Development of glyburide fast-dissolving tablets based on the combined use of cyclodextrins and polymers.
Cirri M; Righi MF; Maestrelli F; Mura P; Valleri M
Drug Dev Ind Pharm; 2009 Jan; 35(1):73-82. PubMed ID: 18821153
[TBL] [Abstract][Full Text] [Related]
6. Characterization and dissolution properties of ketoprofen in binary and ternary solid dispersions with polyethylene glycol and surfactants.
Mura P; Moyano JR; González-Rodríguez ML; Rabasco-Alvaréz AM; Cirri M; Maestrelli F
Drug Dev Ind Pharm; 2005 May; 31(4-5):425-34. PubMed ID: 16093208
[TBL] [Abstract][Full Text] [Related]
7. Solid dispersion adsorbates for enhancement of dissolution rates of drugs.
Deepti ; Dureja H; Madan AK
PDA J Pharm Sci Technol; 2007; 61(2):97-101. PubMed ID: 17479717
[TBL] [Abstract][Full Text] [Related]
8. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
Leonardi D; Barrera MG; Lamas MC; Salomón CJ
AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.
Liu C; Desai KG
Pharm Dev Technol; 2005; 10(4):467-77. PubMed ID: 16370176
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical characterization of gliclazide-macrogol solid dispersion and tablets based on optimized dispersion.
Khattab IS; Nada A; Zaghloul AA
Drug Dev Ind Pharm; 2010 Aug; 36(8):893-902. PubMed ID: 20196643
[TBL] [Abstract][Full Text] [Related]
11. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.
Salazar J; Müller RH; Möschwitzer JP
Eur J Pharm Sci; 2013 Jul; 49(4):565-77. PubMed ID: 23587645
[TBL] [Abstract][Full Text] [Related]
12. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
[TBL] [Abstract][Full Text] [Related]
13. Comparative dissolution studies for mefenamic acid-polyethylene glycol solid dispersion systems and tablets.
Owusu-Ababio G; Ebube NK; Reams R; Habib M
Pharm Dev Technol; 1998 Aug; 3(3):405-12. PubMed ID: 9742561
[TBL] [Abstract][Full Text] [Related]
14. Insight into the Dissolution Molecular Mechanism of Ternary Solid Dispersions by Combined Experiments and Molecular Simulations.
Han R; Huang T; Liu X; Yin X; Li H; Lu J; Ji Y; Sun H; Ouyang D
AAPS PharmSciTech; 2019 Aug; 20(7):274. PubMed ID: 31385095
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery.
Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA
Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185
[TBL] [Abstract][Full Text] [Related]
16. Unexpected differences in dissolution behavior of tablets prepared from solid dispersions with a surfactant physically mixed or incorporated.
de Waard H; Hinrichs WL; Visser MR; Bologna C; Frijlink HW
Int J Pharm; 2008 Feb; 349(1-2):66-73. PubMed ID: 17804180
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization and tableting of cilnidipine solid dispersions.
Hu L; Song W; Niu F; Jiao K; Jia Z
Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
[TBL] [Abstract][Full Text] [Related]
18. Bilayer Tablet Formulation of Metformin HCl and Acarbose: A Novel Approach To Control Diabetes.
Tiwari R; Gupta A; Joshi M; Tiwari G
PDA J Pharm Sci Technol; 2014; 68(2):138-52. PubMed ID: 24668601
[TBL] [Abstract][Full Text] [Related]
19. Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5.
Janssens S; de Armas HN; Roberts CJ; Van den Mooter G
J Pharm Sci; 2008 Jun; 97(6):2110-20. PubMed ID: 17847067
[TBL] [Abstract][Full Text] [Related]
20. Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100.
Goddeeris C; Willems T; Houthoofd K; Martens JA; Van den Mooter G
Eur J Pharm Biopharm; 2008 Nov; 70(3):861-8. PubMed ID: 18691650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
